Concert Pharma (CNCE) to Offer Common Stock

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Concert. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Jefferies is acting as sole book-running manager for the proposed offering. Concert intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering on the same terms and conditions.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• Silence Therapeutics closes $201M public offering of ADSs